Abstract
Gjennomgangen av materialet fra Ullevål Sykehus viser at det er lite komplikasjoner forbundet med behandlingen. Dette betyr at det er god effekt av nøyaktig seleksjon av pasienter til perkutan vertebroplastikk. Det er nødvendig med flere studier for å vurdere betydningen av vertebroplastikk ved osteoporotiske kompresjonsfrakturer. Nytten ved osteolytiske metastaser, myelomatose og atypiske hemangiomer er stor.
Purpose: To evaluate the efficacy and safety of percutaneous vertebroplasty as treatment for painful osteoporotic compression fractures. Material and Methods: We performed a retrospective analysis of all the patients treated with vertebroplasty at Ullevål Sykehus from 2005 to 2012, including age, gender, diagnosis, number of treated levels, sideeffects, complications, refracture rate, operator, and efficacy with VAS Score. Results: 129 patients (51 men, 68 women, mean age 69,8 years, age range 31-90 years) were treated by 139 procedures at 221 levels (mean number of treated levels 1.6, range 1-6 levels per procedure). 2 patients had sementembolus to the lungs, none with symptoms. One patient with COPD had respiratory distress. Noone experienced neurologic deficit, and no patients died. Mean reduction in VAS by 5 patients was 5,2. Conclusion: The importance of thorough selection of patients for treatment can not be underestimated. Vertebroplasty has a low complication rate. More studies are necessary to evaluate the efficacy of vertebroplasty.